Schizophrenia, +/- ? I've been wondering why Cashman's pr comment on schizophrenia seemed a little upbeat, I think it comes down to timing. This 2019 study seems to have opened an avenue for investigation for which our platform is well suited.
https://ictr.johnshopkins.edu/news_announce/physical-evidence-in-the-brain-for-types-of-schizophrenia/
The parallels with AD are obvious but if there's no prion-like spreading then what's the pathology? That's why we're paying Carsten Korth.
https://www.neurosciences-duesseldorf.de/fileadmin/redaktion/Kooperationen/iCAN/120713high_res_final_-p94-96_Carsten_Korth.pdf
I like the idea of a therapeutic target that can produce immediate lab results, multiple protein targets and lots of dead rats. I really hate rats.